{
    "clinical_study": {
        "@rank": "87511", 
        "acronym": "ViaValve-001", 
        "arm_group": [
            {
                "arm_group_label": "ViaValve\u2122 Safety IV Catheter", 
                "arm_group_type": "Active Comparator", 
                "description": "Insertion of the ViaValve\u2122 Safety IV Catheter"
            }, 
            {
                "arm_group_label": "ProtectIV\u00ae Plus Safety IV Catheter", 
                "arm_group_type": "Active Comparator", 
                "description": "Insertion of the ProtectIV\u00ae Plus Safety IV Catheter"
            }
        ], 
        "brief_summary": {
            "textblock": "The objective of this post-market, prospective study is to evaluate the clinical\n      acceptability, blood leakage, risk for blood exposure, need for digital compression,\n      insertion success, and clinical utility of the ViaValve\u2122 Safety IV Catheter compared to\n      standard hospital PIVCs currently being used."
        }, 
        "brief_title": "A Study Evaluating the Clinical Performance of the ViaValve\u2122 Safety IV Catheter", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Actual"
        }, 
        "condition": "Peripheral Intravenous Catheter", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  A peripheral intravenous catheter will need to be inserted in order to gain access to\n             a vein or artery to sample blood, monitor blood pressure, or administer fluids\n             intravenous infusion as part of treatment.\n\n          -  Willing and able to sign an Informed Consent (patient or legally authorized\n             representative).\n\n        Exclusion Criteria:\n\n          -  Body morphology (e.g., size) precludes the use of a peripheral intravenous catheter.\n\n          -  Fluid to be infused is not appropriate for peripheral intravenous catheters."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "150", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "July 12, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02119351", 
            "org_study_id": "ViaValve Study"
        }, 
        "intervention": [
            {
                "arm_group_label": "ViaValve\u2122 Safety IV Catheter", 
                "description": "Safety peripheral IV catheter with a blood control feature", 
                "intervention_name": "ViaValve\u2122 Safety IV Catheter", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "ProtectIV\u00ae Plus Safety IV Catheter", 
                "description": "Safety peripheral IV catheter with no blood control feature", 
                "intervention_name": "ProtectIV\u00ae Plus Safety IV Catheter", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": [
            "peripheral intravenous catheters", 
            "blood exposure", 
            "blood control", 
            "IV catheter insertion"
        ], 
        "lastchanged_date": "April 18, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Calgary", 
                    "country": "Canada", 
                    "state": "Alberta"
                }, 
                "name": "Foothills Medical Centre"
            }
        }, 
        "location_countries": {
            "country": "Canada"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Post-market, Randomized Study Evaluating the Clinical Performance of the ViaValve\u2122 Safety IV Catheter", 
        "overall_official": {
            "affiliation": "U of Calgary and Alberta Health Services", 
            "last_name": "Andrew McRae, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "description": "Demonstrate non-inferiority of the ViaValve\u2122 Safety I.V. Catheter compared to the control PIVC for ratings of clinical acceptability.  Clinicians will agree or disagree that the device was clinically acceptable for the insertion.", 
                "measure": "Clinical acceptability of PIVC insertion", 
                "safety_issue": "No", 
                "time_frame": "Clinicians will provide the rating immediately after performing the insertion"
            }, 
            {
                "description": "Demonstrate superiority of the ViaValve\u2122 Safety I.V. Catheter compared to the control in preventing blood leakage from the catheter hub during insertion.", 
                "measure": "Frequency of blood leakage", 
                "safety_issue": "No", 
                "time_frame": "Clinicians will report if blood leakage occurred immediately after the catheter insertion"
            }, 
            {
                "description": "Demonstrate superiority of the ViaValve\u2122 Safety I.V. Catheter compared to the control PIVC in eliminating the clinician's risk of blood exposure during the insertion process.", 
                "measure": "Eliminating risk of blood exposure", 
                "safety_issue": "No", 
                "time_frame": "Clinicians will report on the ability of the PIVC to eliminate blood exposure immediately after catheter insertion"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02119351"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Demonstrate the insertion success rate of the ViaValve\u2122 I.V. Catheter is non-inferior to the control PIVC. Insertion success defined as a catheter confirmed successfully placed within the selected vessel in 3 or fewer venipuncture attempts.", 
                "measure": "Insertion success", 
                "safety_issue": "No", 
                "time_frame": "Clinicians will report if the insertion was successful immediately after performing insertion"
            }, 
            {
                "description": "Demonstrate that the ViaValve\u2122 Safety I.V. Catheter is non-inferior to the control PIVC in eliminating the clinician's need to use digital compression during the insertion process. Clinicians will agree or disagree the device eliminates the need for digital compression after each PIVC insertion.", 
                "measure": "Elimination of digital compression", 
                "safety_issue": "No", 
                "time_frame": "Clinicians will provide the rating immediately after performing the insertion"
            }, 
            {
                "description": "Demonstrate that the ViaValve\u2122 Safety I.V. Catheter is non-inferior to the control PIVC in seven measures of ease of use. Clinicians will agree or disagree with seven statements regarding ease of use/clinical utility.", 
                "measure": "Ease of Use", 
                "safety_issue": "No", 
                "time_frame": "Clinicians will provide the rating immediately after performing the insertion"
            }
        ], 
        "source": "Smiths Medical, ASD, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Smiths Medical, ASD, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}